List view / Grid view
The Board of AstraZeneca PLC notes the announcement by Pfizer…
20 May 2014 | By AstraZeneca
The Board of AstraZeneca PLC notes the announcement by Pfizer Inc. of its final proposal, comprising £24.76 in cash (45%) and 1.747 Pfizer shares (55%) per AstraZeneca share, representing a value of £55.00 per AstraZeneca share (based on the closing price of Pfizer shares on 16 May 2014...
AstraZeneca announced that Ann Cairns will be proposed to shareholders…
20 March 2014 | By AstraZeneca
AstraZeneca announced that Ann Cairns will be proposed to shareholders for election as a Non-Executive Director at the Company’s Annual General Meeting on 24 April 2014...
"Following a thorough and extensive search it became clear that…
"Following a thorough and extensive search it became clear that Marc possessed the rare blend of financial, business and science experience..."
AstraZeneca today announced that Pascal Soriot has been appointed as…
AstraZeneca today announced that Pascal Soriot has been appointed as the company’s Chief Executive Officer. Pascal Soriot will take on his new responsibilities and join the AstraZeneca PLC Board as an Executive Director on 1 October 2012.
Leif Johansson proposed to shareholders for election as a Non-Executive…
1 March 2012 | By AstraZeneca
Leif Johansson proposed to shareholders for election as a Non-Executive Director...
